Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

The purpose of this study is to assess the safety of etanercept in patients with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) or psoriatic arthritis (PsA) in Spain

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arthritis, Psoriatic Arthritis Arthritis, Rheumatoid Autoimmune Diseases Bone Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Psoriasis Rheumatic Diseases Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases Spinal Diseases Spondylarthritis Spondylarthropathies Spondylitis

Age range

4 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Madrid, 28007, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

RA or PsA in whom DMARDs/antiTNF antibodies/anti IL1 has been insufficient or inappropriate
Children from 4 to 17 years old with JIA polyarticular

Exclusion criteria

Clinically significant abnormal screening lab values
Patients who are planning to undergo elective surgery during the study period.
Other current autoimmune connective tissue diseases

Treatment and study plan

etanercept

Drug

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

Evaluating Safety and QoL in Patients Treated With Etanercept: an Open Multicenter Study

Important dates

Study start: 2003
Primary completion: 2006
Study completion: 2006
First posted: Sep 19, 2005
Registry last updated: Jun 18, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed